Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma, Inc. | Director | $44M | -$13.9M | -24% | Aug 8, 2025 |
MAZE | Maze Therapeutics, Inc. | Director | Sep 22, 2025 | |||
PLRX | PLIANT THERAPEUTICS, INC. | Director | Jun 29, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|